| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3091623
Max Phase: Preclinical
Molecular Formula: C21H17NO6
Molecular Weight: 379.37
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1nc(Cc2ccccc2Oc2ccccc2)c(C(=O)O)c(C(=O)O)c1O
Standard InChI: InChI=1S/C21H17NO6/c1-12-19(23)18(21(26)27)17(20(24)25)15(22-12)11-13-7-5-6-10-16(13)28-14-8-3-2-4-9-14/h2-10,23H,11H2,1H3,(H,24,25)(H,26,27)
Standard InChI Key: SCFALBJIJMZSOU-UHFFFAOYSA-N
Associated Targets(Human)
P2X purinoceptor 7 5534 Activities
P2X purinoceptor 3 1991 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
P2X purinoceptor 1 68 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 379.37 | Molecular Weight (Monoisotopic): 379.1056 | AlogP: 3.88 | #Rotatable Bonds: 6 |
| Polar Surface Area: 116.95 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.56 | CX Basic pKa: 2.06 | CX LogP: 3.85 | CX LogD: -1.73 |
| Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.59 | Np Likeness Score: -0.22 |
References
| 1. Cho JH, Jung KY, Jung Y, Kim MH, Ko H, Park CS, Kim YC.. (2013) Design and synthesis of potent and selective P2X₃ receptor antagonists derived from PPADS as potential pain modulators., 70 [PMID:24246730] [10.1016/j.ejmech.2013.10.026] |
Source
Source(1):